Literature DB >> 10457315

Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter.

M P Ritter1, J H Peters, T R DeMeester, P F Crookes, R J Mason, L Green, L Tefera, C G Bremner.   

Abstract

With the advent of laparoscopic surgery and the recognition that gastroesophageal reflux disease often requires lifelong medication, patients with normal resting sphincter characteristics are now being considered for surgery. The outcome of these patients after fundoplication is unknown and formed the basis of this study. The study population consisted of 123 patients undergoing laparoscopic Nissen fundoplication between 1992 and 1996. All patients had increased esophageal acid exposure on 24-hour esophageal pH monitoring. Patients were divided into those with a normal (n = 36) and those with a structurally defective (n = 87) lower esophageal sphincter (LES), based on LES resting pressure (normal >6 mm Hg), overall length (normal >2 cm), and abdominal length (normal >1 cm), and their outcomes were assessed. Each group was subsequently divided into patients presenting with a primary symptom that was "typical" (heartburn, regurgitation, or dysphagia) or "atypical" (gastric, respiratory, or chest pain) of gastro-esophageal reflux, and outcome was assessed. Median duration of follow-up was 18 months after surgery. Overall, laparoscopic fundoplication was successful in relieving symptoms of gastroesophageal reflux in 90% of patients. Patients with a typical primary symptom had an excellent outcome irrespective of the resting status of the LES (95% and 97%, respectively). Atypical primary symptoms were significantly more common in patients with a normal LES (29%) than in those with a structurally defective LES (10%; P <0.05), and these symptoms were less likely (50%) to be relieved by antireflux surgery. Laparoscopic antireflux surgery is highly successful and not dependent on the status of the resting LES in patients with increased esophageal acid exposure and primary symptoms "typical" of gastroesophageal reflux. Antireflux surgery should be applied cautiously in patients with atypical primary symptoms.

Entities:  

Mesh:

Year:  1998        PMID: 10457315     DOI: 10.1016/s1091-255x(98)80058-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Diaphragmatic contribution to gastroesophageal competence and reflux in dogs.

Authors:  C J Martin; W J Dodds; H H Liem; R O Dantas; R D layman; J Dent
Journal:  Am J Physiol       Date:  1992-10

2.  Electrical and mechanical inhibition of the crural diaphragm during transient relaxation of the lower esophageal sphincter.

Authors:  R K Mittal; M J Fisher
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

3.  Nissen fundoplication prevents shortening of the sphincter during gastric distention.

Authors:  R J Mason; T R DeMeester; R J Lund; J H Peters; P Crookes; M Ritter; M Gadenstätter; J A Hagen
Journal:  Arch Surg       Date:  1997-07

Review 4.  Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease.

Authors:  T R DeMeester; A P Ireland
Journal:  Dis Esophagus       Date:  1997-01       Impact factor: 3.429

5.  Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux.

Authors:  F Johnsson; R H Holloway; A C Ireland; G G Jamieson; J Dent
Journal:  Br J Surg       Date:  1997-05       Impact factor: 6.939

6.  Mechanisms underlying the antireflux action of fundoplication.

Authors:  A C Ireland; R H Holloway; J Toouli; J Dent
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

7.  Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease.

Authors:  R A Hinder; C J Filipi; G Wetscher; P Neary; T R DeMeester; G Perdikis
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

8.  A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  J G Hunter; T L Trus; G D Branum; J P Waring; W C Wood
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

9.  Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.

Authors:  J Dent; R H Holloway; J Toouli; W J Dodds
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

10.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

View more
  6 in total

Review 1.  The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus.

Authors:  J H Peters
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

2.  Response of the lower esophageal sphincter to gastric distention by carbonated beverages.

Authors:  Nahid Hamoui; Reginald V Lord; Jeffrey A Hagen; Joerg Theisen; Tom R Demeester; Peter F Crookes
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

3.  Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease.

Authors:  V Velanovich; R Karmy-Jones
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

4.  Preoperative lower esophageal sphincter manometry data neither impact manifestations of GERD nor outcome after laparoscopic Nissen fundoplication.

Authors:  Otto Riedl; Michael Gadenstätter; Wolfgang Lechner; Gerhard Schwab; Martina Marker; Ruxandra Ciovica
Journal:  J Gastrointest Surg       Date:  2009-04-16       Impact factor: 3.452

5.  Normal lower esophageal sphincter pressure and length does not impact outcome after laparoscopic Nissen fundoplication.

Authors:  Sarah M Cowgill; Mark Bloomston; Sam Al-Saadi; Desiree Villadolid; Alexander S Rosemurgy
Journal:  J Gastrointest Surg       Date:  2007-06       Impact factor: 3.267

6.  Use of acid suppressive medications after laparoscopic antireflux surgery: prevalence and clinical indications.

Authors:  Hugo Bonatti; Tanja Bammer; Sami R Achem; Frank Lukens; Kenneth R DeVault; Alexander Klaus; Ronald A Hinder
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.